1. Home
  2. ITGR vs AB Comparison

ITGR vs AB Comparison

Compare ITGR & AB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITGR
  • AB
  • Stock Information
  • Founded
  • ITGR 1970
  • AB 1987
  • Country
  • ITGR United States
  • AB United States
  • Employees
  • ITGR N/A
  • AB N/A
  • Industry
  • ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • AB Investment Managers
  • Sector
  • ITGR Health Care
  • AB Finance
  • Exchange
  • ITGR Nasdaq
  • AB Nasdaq
  • Market Cap
  • ITGR 4.1B
  • AB 4.2B
  • IPO Year
  • ITGR 2000
  • AB 1988
  • Fundamental
  • Price
  • ITGR $118.02
  • AB $38.30
  • Analyst Decision
  • ITGR Strong Buy
  • AB Strong Buy
  • Analyst Count
  • ITGR 9
  • AB 5
  • Target Price
  • ITGR $148.56
  • AB $43.00
  • AVG Volume (30 Days)
  • ITGR 633.2K
  • AB 978.8K
  • Earning Date
  • ITGR 04-24-2025
  • AB 04-24-2025
  • Dividend Yield
  • ITGR N/A
  • AB 8.51%
  • EPS Growth
  • ITGR 25.44
  • AB 58.60
  • EPS
  • ITGR 3.37
  • AB 3.71
  • Revenue
  • ITGR $1,716,596,000.00
  • AB N/A
  • Revenue This Year
  • ITGR $10.86
  • AB N/A
  • Revenue Next Year
  • ITGR $7.41
  • AB N/A
  • P/E Ratio
  • ITGR $35.18
  • AB $10.32
  • Revenue Growth
  • ITGR 10.35
  • AB N/A
  • 52 Week Low
  • ITGR $107.11
  • AB $30.57
  • 52 Week High
  • ITGR $146.36
  • AB $41.37
  • Technical
  • Relative Strength Index (RSI)
  • ITGR 39.90
  • AB 57.13
  • Support Level
  • ITGR $110.84
  • AB $37.77
  • Resistance Level
  • ITGR $120.10
  • AB $38.48
  • Average True Range (ATR)
  • ITGR 3.51
  • AB 0.39
  • MACD
  • ITGR 0.58
  • AB 0.08
  • Stochastic Oscillator
  • ITGR 65.27
  • AB 89.57

About ITGR Integer Holdings Corporation

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.

About AB AllianceBernstein Holding L.P.

AllianceBernstein provides investment management services to institutional (42% of assets under management), retail (41%), and private (17%) clients through products that includes mutual funds, hedge funds, and separately managed accounts. At the end of October 2024, AB had $793 billion in managed assets, composed primarily of fixed-income (37% of AUM) and equity (42%) strategies, with other investments (made up of asset allocation services and certain other alternative investments) accounting for the remainder.

Share on Social Networks: